Two device company executives have stepped away from the path of smart technology, instead offering new capabilities in a simple, yet groundbreaking way.

Device manufacturers in California and Israel have recently unveiled ophthalmic devices that are the hallmark of simplicity yet may also provide groundbreaking opportunities in patient care, bringing a whole new meaning to the Keep It Super Simple (KISS) method.

CorNeat Vision, based in Ra’anana, Israel, recently received FDA 510(k) approval for its synthetic surgical patch, the EverPatch. The Mountain View, CA-based Smartlens also recently received $6.1 million in funding to pave the way for further trials and possible FDA approval during 2024 for its miLens soft contact lens that measures intraocular pressure.

Both devices eschew any sort of smart technology such as electronics or communications modules, but executives of both companies say they offer new capabilities that can make care easier for both clinicians and patients. Of course, they say, the principles and materials science behind the devices go back several years.